Pulmonx Corp - COM (LUNG)

Historical Holders from Q4 2020 to Q4 2025

Type / Class
Equity / COM
Symbol
LUNG on Nasdaq
Shares outstanding
40,762,262
Price per share
$2.22
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
31,835,102
Holdings value
$51,571,421
% of all portfolios
0%
Share change
-4,417,027
Value change
-$11,678,480
Average buys %
+0%
Average sells %
-0%
Number of holders
103
Price from insider filings
$1.99
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Pulmonx Corp - COM (LUNG) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PRIMECAP MANAGEMENT CO/CA/ 12% -10% $8,029,839 -$742,073 4,956,691 -8.5% PRIMECAP MANAGEMENT CO/CA/ 30 Sep 2025
MORGAN STANLEY 8.5% +12% $22,819,660 +$2,863,898 3,390,737 +14% Morgan Stanley 31 Mar 2025
BlackRock, Inc. 6.8% $18,137,337 2,694,998 BlackRock, Inc. 31 Mar 2025
FMR LLC 0.2% -104% $114,736 -$3,416,852 70,825 -97% FMR LLC 31 Oct 2025
As of 30 Sep 2025, Pulmonx Corp - COM (LUNG) has 103 institutional shareholders filing 13F forms. They hold 31,835,102 shares of 40,762,262 outstanding shares (78%) .

Top 25 institutional shareholders own 70% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
PRIMECAP MANAGEMENT CO/CA/ 12% 4,956,691 -4% 0.01% $8,029,840
MORGAN STANLEY 8.9% 3,620,676 +1.8% 0% $5,865,496
BlackRock, Inc. 6.6% 2,674,821 -0.59% 0% $4,333,210
VANGUARD GROUP INC 5.5% 2,242,187 -2.3% 0% $3,632,343
FMR LLC 5.3% 2,174,358 -49% 0% $3,522,461
SILVERCREST ASSET MANAGEMENT GROUP LLC 3.1% 1,264,233 +36% 0.01% $2,048,057
DEUTSCHE BANK AG\ 2.8% 1,125,861 0% 0% $1,823,895
GEODE CAPITAL MANAGEMENT, LLC 2.4% 978,762 +5.3% 0% $1,585,857
Kent Lake PR LLC 2.3% 926,157 0.77% $1,500,374
Vestal Point Capital, LP 2% 830,000 0.06% $1,344,600
STATE STREET CORP 1.9% 792,404 -0.22% 0% $1,283,694
D. E. Shaw & Co., Inc. 1.9% 789,249 +61% 0% $1,278,584
GSA CAPITAL PARTNERS LLP 1.9% 755,467 +78% 0.1% $1,224,000
BRAIDWELL LP 1.8% 752,541 0% 0.04% $1,219,116
Stonepine Capital Management, LLC 1.6% 670,000 +359% 0.88% $1,085,400
Parkman Healthcare Partners LLC 1.2% 500,662 -17% 0.09% $811,072
JPMORGAN CHASE & CO 1.2% 497,102 -16% 0% $805,306
BANK OF AMERICA CORP /DE/ 1.2% 479,023 -0.47% 0% $776,017
GOLDMAN SACHS GROUP INC 0.97% 394,890 +88% 0% $639,721
NORTHERN TRUST CORP 0.89% 362,371 +1.9% 0% $587,041
DIMENSIONAL FUND ADVISORS LP 0.85% 344,467 -24% 0% $558,151
BARCLAYS PLC 0.83% 339,682 +25% 0% $550,285
MILLENNIUM MANAGEMENT LLC 0.82% 335,849 -71% 0% $544,075
RENAISSANCE TECHNOLOGIES LLC 0.82% 332,810 +32% 0% $539,152
Jefferies Financial Group Inc. 0.7% 285,110 0% 0% $461,878

Institutional Holders of Pulmonx Corp - COM (LUNG) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 12,852 $28,652 -$27,411 $2.22 2
2025 Q3 31,835,102 $51,571,421 -$11,678,480 $1.62 103
2025 Q2 36,256,022 $93,898,311 -$4,596,863 $2.59 113
2025 Q1 36,156,132 $243,325,045 +$1,662,991 $6.73 114
2024 Q4 35,871,067 $243,568,283 +$2,668,124 $6.79 117
2024 Q3 35,412,137 $292,557,777 +$6,899,463 $8.29 112
2024 Q2 34,744,517 $220,279,793 +$16,547,937 $6.34 108
2024 Q1 3,530,814 $32,731,335 -$14,218,104 $9.27 9
2023 Q4 15,136 $192,984 $12.75 1
2023 Q3 101 $2,000 -$2,376,415 $19.80 2
2023 Q2 33,491,872 $439,046,096 -$14,151,788 $13.11 111
2023 Q1 34,707,525 $388,030,790 +$28,526,532 $11.18 100
2022 Q4 33,700,796 $284,097,415 -$83,328,505 $8.43 108
2022 Q3 33,043,464 $550,499,375 -$341,462 $16.66 96
2022 Q2 35,323,593 $519,929,047 -$7,926,022 $14.72 99
2022 Q1 34,353,814 $852,189,885 +$57,192,569 $24.81 101
2021 Q4 31,762,309 $1,018,622,027 +$25,810,183 $32.07 105
2021 Q3 31,599,592 $1,136,954,158 +$204,391,965 $35.98 117
2021 Q2 25,854,693 $1,140,627,052 +$183,972,667 $44.12 114
2021 Q1 21,603,795 $988,158,909 +$115,760,338 $45.74 109
2020 Q4 18,401,048 $1,256,450,046 +$1,018,297,205 $69.02 99